Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain
· Delayed Price · Currency is EUR 2.800
+0.050 (1.82%)
At close: Dec 5, 2025
Laboratorio Reig Jofre Revenue
Laboratorio Reig Jofre had revenue of 72.77M EUR in the quarter ending September 30, 2025, a decrease of -8.23%. This brings the company's revenue in the last twelve months to 330.34M, down -1.00% year-over-year. In the year 2024, Laboratorio Reig Jofre had annual revenue of 341.37M with 7.36% growth.
Revenue (ttm)
330.34M
Revenue Growth
-1.00%
P/S Ratio
0.69
Revenue / Employee
229.88K
Employees
1,437
Market Cap
227.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 341.37M | 23.42M | 7.36% |
| Dec 31, 2023 | 317.95M | 43.74M | 15.95% |
| Dec 31, 2022 | 274.21M | 34.34M | 14.32% |
| Dec 31, 2021 | 239.87M | 6.11M | 2.61% |
| Dec 31, 2020 | 233.76M | 27.93M | 13.57% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Laboratorios Farmaceuticos Rovi | 724.20M |
| Almirall | 1.09B |
| Faes Farma | 571.12M |
| Pharma Mar | 179.28M |
| Clínica Baviera | 296.76M |
| Oryzon Genomics | 7.36M |
| Prim, S.A. | 240.68M |